SELVAS Healthcare, Inc. (KOSDAQ:208370)
4,250.00
+60.00 (1.43%)
At close: Apr 3, 2026
SELVAS Healthcare Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9,382 | 13,765 | 9,818 | 4,399 | 9,872 |
Short-Term Investments | 16,995 | 12,323 | - | - | 5,000 |
Trading Asset Securities | - | - | 14,462 | 2,662 | - |
Cash & Short-Term Investments | 26,376 | 26,089 | 24,280 | 7,061 | 14,872 |
Cash Growth | 1.10% | 7.45% | 243.84% | -52.52% | 9.03% |
Accounts Receivable | 7,962 | 8,317 | 4,852 | 3,765 | 3,261 |
Other Receivables | 668.42 | 409.48 | 347.81 | 71.93 | 151.85 |
Receivables | 9,192 | 9,384 | 5,768 | 4,482 | 4,004 |
Inventory | 8,115 | 7,588 | 9,960 | 8,897 | 5,208 |
Prepaid Expenses | 348.86 | 306.45 | 361.98 | 158.83 | 220.37 |
Other Current Assets | 1,768 | 601.17 | 410.13 | 1,086 | 1,747 |
Total Current Assets | 45,800 | 43,968 | 40,781 | 21,685 | 26,051 |
Property, Plant & Equipment | 24,015 | 16,463 | 15,928 | 16,017 | 14,132 |
Long-Term Investments | 5,499 | 3,520 | 3,377 | - | 359.58 |
Goodwill | 2,526 | 2,526 | 2,526 | 2,526 | 2,526 |
Other Intangible Assets | 268.95 | 142.46 | 313.91 | 533.12 | 739.79 |
Long-Term Accounts Receivable | 72.06 | 162.49 | 247.94 | 328.67 | - |
Other Long-Term Assets | 669.91 | 3,336 | 3,421 | 4,925 | 5,132 |
Total Assets | 78,988 | 70,223 | 66,680 | 46,034 | 48,984 |
Accounts Payable | 388.6 | 248.33 | 336.69 | 246.46 | 409.22 |
Accrued Expenses | 1,607 | 1,443 | 1,463 | 1,025 | 824.99 |
Short-Term Debt | 1,050 | 1,652 | 833.19 | 787.91 | 7,233 |
Current Portion of Long-Term Debt | - | 600 | 2,045 | 5,200 | 6,540 |
Current Portion of Leases | 238.21 | 199.26 | 202.98 | 199.99 | 209.23 |
Current Income Taxes Payable | 37.74 | - | - | - | - |
Other Current Liabilities | 1,683 | 1,301 | 1,258 | 1,411 | 1,700 |
Total Current Liabilities | 5,005 | 5,444 | 6,139 | 8,870 | 16,916 |
Long-Term Debt | - | - | - | 1,495 | 2,460 |
Long-Term Leases | 436.1 | 544.68 | 158.12 | 150.04 | 311.39 |
Long-Term Deferred Tax Liabilities | 2,192 | 257.34 | 110.4 | 1,429 | 982.48 |
Other Long-Term Liabilities | 230.69 | 176.59 | 175.94 | 330.36 | 253.74 |
Total Liabilities | 7,863 | 6,423 | 6,583 | 12,274 | 20,924 |
Common Stock | 12,870 | 12,870 | 12,840 | 10,840 | 10,840 |
Additional Paid-In Capital | 50,933 | 50,933 | 50,646 | 31,892 | 31,812 |
Retained Earnings | -2,071 | -5,960 | -9,112 | -14,558 | -18,151 |
Treasury Stock | -177.03 | -177.03 | -177.03 | -177.03 | -177.03 |
Comprehensive Income & Other | 9,570 | 6,134 | 5,899 | 5,762 | 3,736 |
Total Common Equity | 71,125 | 63,801 | 60,097 | 33,759 | 28,060 |
Shareholders' Equity | 71,125 | 63,801 | 60,097 | 33,759 | 28,060 |
Total Liabilities & Equity | 78,988 | 70,223 | 66,680 | 46,034 | 48,984 |
Total Debt | 1,725 | 2,996 | 3,239 | 7,833 | 16,753 |
Net Cash (Debt) | 24,652 | 23,092 | 21,041 | -771.46 | -1,881 |
Net Cash Growth | 6.75% | 9.75% | - | - | - |
Net Cash Per Share | 957.16 | 893.83 | 870.30 | -32.65 | -86.85 |
Filing Date Shares Outstanding | 25.87 | 25.72 | 25.66 | 21.66 | 21.66 |
Total Common Shares Outstanding | 25.87 | 25.72 | 25.66 | 21.66 | 21.66 |
Working Capital | 40,795 | 38,524 | 34,642 | 12,815 | 9,135 |
Book Value Per Share | 2749.56 | 2480.82 | 2342.27 | 1558.78 | 1295.64 |
Tangible Book Value | 68,330 | 61,132 | 57,257 | 30,701 | 24,795 |
Tangible Book Value Per Share | 2641.52 | 2377.07 | 2231.59 | 1417.54 | 1144.86 |
Land | 13,318 | 8,272 | 8,272 | 8,272 | 6,660 |
Buildings | 8,355 | 6,749 | 6,749 | 6,749 | 6,303 |
Machinery | 5,395 | 5,065 | 4,540 | 5,134 | 7,928 |
Construction In Progress | 799.08 | 273.89 | 140.83 | 11.15 | 20.65 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.